Greenwich Lifesciences Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -32,900.8% | – | – | – | -50,787.8% | – | – | – | -132,166.9% | – | -350,987.6% | |
| – | – | 16.7% | – | – | – | 25.0% | – | – | – | 0.0% | – | – | |
| – | – | 10,973.1% | – | – | – | 42,752.3% | – | – | – | 43,401.2% | – | 189,541.1% | |
| – | – | 1,757.2% | – | – | – | -3,355.7% | – | – | – | -16,570.4% | – | 64,484.7% | |
| – | – | 0.1% | – | – | – | 0.1% | – | – | – | 0.1% | – | 0.3% | |
| – | – | 5,520.8% | – | – | – | 13,633.0% | – | – | – | 253,791.8% | – | 512,630.5% | |
| – | – | -27,380.0% | – | – | – | -37,154.8% | – | – | – | 121,624.9% | – | 161,642.8% | |
| – | – | -32,900.8% | – | – | – | -50,787.8% | – | – | – | -132,166.9% | – | -350,987.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.